| Literature DB >> 30700266 |
Esteban Londoño Agudelo1, Armando Rodríguez Salvá2, Addys Díaz Piñera2, René García Roche2, Pol De Vos3, Tullia Battaglioli4, Patrick Van der Stuyft5.
Abstract
BACKGROUND: To determine the prevalence of hypertension treatment and control among hypertensive patients in the Cuban municipalities of Cardenas and Santiago and to explore the main associated predictors.Entities:
Keywords: Antihypertensive agents; Chronic disease; Cuba; Hypertension; Primary health care; Treatment
Mesh:
Substances:
Year: 2019 PMID: 30700266 PMCID: PMC6354370 DOI: 10.1186/s12872-019-1006-6
Source DB: PubMed Journal: BMC Cardiovasc Disord ISSN: 1471-2261 Impact factor: 2.298
General characteristics, blood pressure parameters, hypertension treatment and control, by health area, in hypertensive patients in the municipalities of Cardenas and Santiago, Cuba, 2012–2013
| Total ( | Cardenas | Santiago | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| No. (%) / mean | 95% CI | JAE (No. = 292) | Moncada (No. = 346) | Finlay (No. = 351) | Grimau (No. = 344) | |||||
| No. (%)/ mean | 95% CI | No. (%) / mean | 95% CI | No. (%) / mean | 95% CI | No. (%) / mean | 95% CI | |||
| Female sex | 819 (61) | 59–64 | 164 (56) | 50–62 | 194 (56) | 51–61 | 218 (62) | 57–67 | 243 (71) | 66–75 |
| Age (years) | 59.8 | 59.1–60.6 | 58.7 | 57.1–60.3 | 59.2 | 57.9–60.7 | 62.5 | 61.0–63.9 | 58.7 | 57.2–60.2 |
| Non-white ethnicity | 758 (57) | 54–60 | 92 (32) | 26–37 | 127 (37) | 7–14 | 236 (67) | 62–72 | 303 (88) | 85–92 |
| Post-primary education | 1128 (85) | 83–87 | 265 (91) | 87–94 | 261 (75) | 71–80 | 310 (88) | 85–92 | 292 (85) | 81–89 |
| Single civil status | 571 (43) | 40–45 | 112 (38) | 33–44 | 130 (38) | 32–43 | 174 (50) | 44–55 | 155 (45) | 40–50 |
| Paid job | 522 (39) | 37–42 | 143 (49) | 43–55 | 127 (37) | 32–42 | 125 (36) | 31–41 | 127 (37) | 32–42 |
| Body Mass Index | ||||||||||
| Underweight | 27 (2) | 1–3* | 5 (2) | 1–4 | 10 (3)* | 1–5* | 6 (2) | 1–4* | 6 (2) | 1–4* |
| Normal weight | 518 (39) | 36–41 | 113 (39) | 33–44 | 113 (33) | 28–38 | 144 (41) | 36–46 | 148 (43) | 38–48 |
| Overweight | 523 (39) | 37–42 | 125 (43) | 37–48 | 139 (40) | 35–45 | 133 (38) | 33–43 | 126 (37) | 32–42 |
| Obese | 265 (20) | 18–22 | 49 (17) | 12–21 | 84 (24) | 20–29 | 68 (19) | 15–24 | 64 (19) | 14–23 |
| Diabetes | 207 (16) | 14–17 | 33 (11) | 8–15 | 40 (12) | 8–15 | 69 (20) | 16–24 | 65 (19) | 15–23 |
| Coronary heart disease | 185 (14) | 12–16 | 26 (9) | 6–12 | 54 (16) | 12–19 | 65 (19) | 14–23 | 40 (12) | 8–15 |
| Blood pressure (mmHg) | ||||||||||
| Systolic | 130.0 | 129.3–130.8 | 128.9 | 127.3–130.5 | 131.7 | 128.7–131.7 | 129.2 | 127.8–130.6 | 130.2 | 128.7–131.7 |
| Diastolic | 83.1 | 82.6–83.6 | 81.5 | 80.4–82.5 | 83.8 | 82.3–84.8 | 84.2 | 83.3–85.2 | 82.6 | 81.7–83.5 |
| On anti-hypertensive pharmacological treatment | 1218 (91) | 90–93 | 284 (97) | 95–99 | 318 (92) | 89–95 | 318 (91) | 87–93 | 298 (87) | 83–92 |
| Controlled hypertension | 773 (58) | 55–61 | 191 (65) | 60–71 | 186 (54) | 48–59 | 187 (53) | 48–59 | 209 (61) | 55–66 |
CI confidence interval, JAE José Antonio Echeverría. * Exact confidence interval
Fig. 1Prevalence of use of main classes of anti-hypertensive drugs. Cardenas and Santiago municipalities, Cuba, 2012–2013. Error bars represent the 95% confidence intervals. ACEi/ARB = Angiotensin Converting Enzyme inhibitor / Angiotensin II Receptor Blocker; B-Blocker = Beta-blocker.; CCB = Calcium Channel Blocker
Fig. 2Prevalence of use of different anti-hypertensive drug combinations. Cardenas and Santiago municipalities, Cuba, 2012–2013. Error bars represent the 95% confidence intervals. ACEi/ARB = Angiotensin Converting Enzyme inhibitor / Angiotensin II Receptor Blocker; B-Blocker = Beta-blocker.; CCB = Calcium Channel Blocker
Predictors of controlled hypertension among hypertensive patients in the municipalities of Cardenas and Santiago, Cuba, 2012–2013
| Predictor | Controlled hypertension, No. (%) | Unadjusted OR (95% CI) | Adjusted OR (95%CI) | |
|---|---|---|---|---|
| No | Yes | |||
| Sex | ||||
| Male | 224 (44) | 290 (56) | Reference | – |
| Female | 336 (41) | 483 (59) | 1.11 (0.89–1.39) | |
| Age in years | ||||
| < 65 | 332 (41) | 475 (59) | 1.10 (0.88–1.37) | – |
| ≥ 65 | 228 (43) | 298 (58) | Reference | |
| Ethnicity | ||||
| Non-white | 338 (45) | 420 (55) | Reference | Ref. |
| White | 222 (39) | 353 (61) | 1.28 (1.03–1.59) | 1.39 (1.08–1.79) |
| Post-primary Education | ||||
| No | 109 (53) | 96 (47) | Reference | Ref. |
| Yes | 451 (40) | 677 (60) | 1.70 (1.26–2.30) | 1.72 (1.26–2.35) |
| Civil status | ||||
| Single | 241 (42) | 330 (58) | Reference | – |
| Married/Partner | 319 (42) | 443 (58) | 1.01 (0.81–1.26) | |
| Paid job | ||||
| No | 222 (43) | 300 (58) | Reference | – |
| Yes | 338 (42) | 473 (58) | 0.97 (0.77–1.20) | |
| Obesity | ||||
| Yes | 131 (49) | 134 (51) | Reference | Ref. |
| No | 429 (40) | 639 (60) | 1.46 (1.11–1.91) | 1.43 (1.09–1.89) |
| Diabetes | ||||
| Yes | 89 (43) | 118 (57) | Reference | – |
| No | 471 (42) | 655 (58) | 1.05 (0.78–1.42) | |
| Coronary heart disease | ||||
| Yes | 79 (43) | 106 (57) | Reference | – |
| No | 481 (42) | 667 (58) | 1.03 (0.75–1.42) | |
| On anti-hypertensive pharmacological treatment | ||||
| ===No | 52 (45) | 63 (55) | Reference | Ref. |
| Yes, non-adherent | 281 (45) | 341 (55) | 1.00 (0.7–1.5) | 1.06 (0.70–1.59) |
| Yes, adherent | 227 (38) | 369 (62) | 1.34 (0.90–2.0) | 1.35 (0.90–2.05) |
| Health area | ||||
| JAE | 101 (35) | 191 (65) | Reference | Ref. |
| Finlay | 164 (47) | 187 (53) | 0.60 (0.45–0.81) | 0.75 (0.54–1.04) |
| Grimau | 135 (39) | 209 (61) | 0.82 (0.60–1.11) | 1.11 (0.78–1.56) |
| Moncada | 160 (46) | 186 (54) | 0.62 (0.46–0.83) | 0.71 (0.52–0.98) |
CI confidence interval, JAE José Antonio Echeverría